MICHAEL WILLOZ: Open Payments
NPI 1255778098 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 5 payments from 5 companies in 2025. Trend: 2023 $620 · 2024 $646 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| Novo Nordisk Inc | 1 | $123 |
| ABBVIE INC. | 1 | $97 |
| UCB, Inc. | 1 | $26 |
Products named: WAINUA, AUSTEDO XR, Wegovy, VRAYLAR, Briviact.
Industry payments across LA — which companies pay providers there.
